Back to Search
Start Over
Inhalation of hydrogen gas protects against mitomycin-induced pulmonary veno-occlusive disease.
- Source :
-
Respiratory research [Respir Res] 2024 Jul 16; Vol. 25 (1), pp. 281. Date of Electronic Publication: 2024 Jul 16. - Publication Year :
- 2024
-
Abstract
- Background: As a subtype of pulmonary hypertension (PH), pulmonary veno-occlusive disease (PVOD) is devastating and life-threatening disease without effective therapy. Hydrogen has been reported to exhibits antioxidant and anti-inflammatory effects in a rat model induced by monocrotaline of PH. In this study, we investigated the effects of inhaled hydrogen gas on the prevention and treatment of PVOD induced by mitomycin C (MMC) in rats.<br />Methods: PVOD was induced in female Sprague-Dawley rats through intraperitoneal injection of MMC at a concentration of 3 mg·kg <superscript>- 1</superscript> ·wk <superscript>- 1</superscript> for 2 weeks. Inhalation of hydrogen gas (H <subscript>2</subscript> ) was administered through a designed rat cage concurrently or two weeks after MMC administration. The severity of PVOD was assessed by using hemodynamic measurements and histological analysis. The expression levels of general control nonderepressible 2 (GCN2), nuclear factor erythroid 2-related factor-2 (Nrf2), heme oxygenase-1 (HO-1) and endothelial-to-mesenchymal transition (EndoMT) related proteins in lung tissue were measured. Levels of lipid peroxidation pro-inflammatory cytokines in serum were determined.<br />Results: Inhaled H <subscript>2</subscript> improved hemodynamics and right heart function, reversed right ventricular hypertrophy, and prevented pulmonary vessel reconstitution in both prevention and treatment approaches. It decreased malondialdehyde (MDA) levels in the serum and the expression of NADPH oxidase 1 (NOX-1) in lung tissue. It regulated Nrf2/HO-1 signaling pathway and anti-inflammatory factor GCN2 in lung tissue, accompanied by a decrease in macrophages and pro-inflammatory cytokines. Our data suggested that H <subscript>2</subscript> inhalation effectively countered EndoMT induced by MMC, as evidenced by the detection of endothelial markers (e.g., VE-cadherin and CD31) and mesenchymal markers (e.g., vimentin and fibronectin). Further research revealed that H <subscript>2</subscript> preserved p-Smad3 and induced p-Smad1/5/9.<br />Conclusion: Inhalation of H <subscript>2</subscript> effectively inhibits the pathogenesis of PVOD induced by MMC in rats. This inhibitory effect may be attributed to the antioxidant and anti-inflammatory properties of H <subscript>2</subscript> .<br /> (© 2024. The Author(s).)
- Subjects :
- Animals
Female
Administration, Inhalation
Rats
Disease Models, Animal
Lung drug effects
Lung metabolism
Lung pathology
Rats, Sprague-Dawley
Hydrogen pharmacology
Hydrogen administration & dosage
Mitomycin administration & dosage
Pulmonary Veno-Occlusive Disease chemically induced
Pulmonary Veno-Occlusive Disease prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1465-993X
- Volume :
- 25
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Respiratory research
- Publication Type :
- Academic Journal
- Accession number :
- 39014440
- Full Text :
- https://doi.org/10.1186/s12931-024-02906-y